Investor · Boston, MA
Peter B. Finn
Open Peter in the network graph →Filings
60
SEC Form D
Connections
228
co-filers
Capital
$95.6M
across filings
Active
Sep 2009
to Jul 2020
Most-connected co-filers (228)
Steven W. Davis · Birmingham, AL12 sharedDaniel M. Rosenbloom · CHICAGO, IL12 sharedEric M. Siegal · CHICAGO, IL12 sharedMatthew Kennedy · New York, NY12 sharedJustin Klee · Cambridge, MA9 sharedStephen D. Chubb · Cambridge, MA9 sharedJoshua Cohen · Cambridge, MA9 sharedGeorge Milne · Cambridge, MA7 sharedRobert S. Hillman · San Diego, CA6 sharedMikhail Plam · Louisville, CO6 sharedNiles C. Utlaut · Louisville, CO6 sharedDavid C. Barker · Louisville, CO6 sharedJames F. Kellogg Iii · Boston, MA6 sharedNikhil Thakur, Md · Andover, MA6 sharedChristopher F. Linneman · Boston, MA6 sharedJonathan J. Desimone · Boston, MA6 sharedWalter Gilbert · Cambridge, MA5 sharedAndrew Winograd · Beverly Hills, CA5 sharedPeter E. Wirth · Cambridge, MA5 sharedIsaac Cheng · Cambridge, MA5 sharedMark Lehrol · Providence, RI5 sharedJoseph E. Cornell · New York, NY5 sharedElisabet De Los Pinos, Ph.D · Cambridge, MA5 sharedFelix Von Coerper · Cambridge, MA5 shared
Recent filings (60)
ZETAGEN THERAPEUTICS, INC.Nov 2025 · 17 co-filers$13.0MZETAGEN THERAPEUTICS, INC.Jan 2025 · 17 co-filers$6.2MCeleCor Therapeutics, Inc.Aug 2024 · 11 co-filers$45.5MCeleCor Therapeutics, Inc.Aug 2023 · 11 co-filers$42.5MZETAGEN THERAPEUTICS, INC.Feb 2023 · 17 co-filers$15.0MAmbergen, Inc.Apr 2022 · 10 co-filers$5.0MCeleCor Therapeutics, Inc.Mar 2022 · 11 co-filers$7.5MCeleCor Therapeutics, Inc.May 2021 · 10 co-filers$5.0MCeleCor Therapeutics, Inc.May 2021 · 10 co-filers$5.0MVigeo Therapeutics, Inc.Mar 2021 · 14 co-filers$17.5MVigeo Therapeutics, Inc.Mar 2021 · 14 co-filers$7.6MBluegrass Equity Fund, LPJan 2021 · 6 co-filerscystetic Medicines, Inc.Nov 2020 · 9 co-filers$25.1Mcystetic Medicines, Inc.Nov 2020 · 9 co-filers$25.1MAmylyx Pharmaceuticals, Inc.Jul 2020 · 23 co-filers$30.0MPULMOQUNE THERAPEUTICS, INC.Apr 2020 · 7 co-filers$5.5MPULMOQUNE THERAPEUTICS, INC.Apr 2020 · 7 co-filers$5.5MAmylyx Pharmaceuticals, Inc.Jan 2020 · 23 co-filers$20.0MBluegrass Equity Fund, LPJan 2020 · 6 co-filersAmylyx Pharmaceuticals, Inc.Dec 2019 · 23 co-filers$15.0MAmylyx Pharmaceuticals, Inc.Dec 2019 · 23 co-filers$15.0MZETAGEN THERAPEUTICS, INC.Dec 2019 · 8 co-filers$8.5MDEEPBIOME THERAPEUTICS, INC.Oct 2019 · 13 co-filers$4.9MCerberus 17 RM Feeder Fund, Ltd.Jun 2019 · 14 co-filersBluegrass Equity Fund, LPJan 2019 · 6 co-filers
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Peter in the interactive graph →